Home | Appointments | About The Center

RA B-Cell Depletion

Clifton Bingham, M.D. - Jon Giles, M.D.

Abstract 6 (Poster): Safety and Clinical Activity of Ocrelizumab (a Humanized Antibody Targeting CD20+ B Cells) in Combination with Methotrexate in Moderate-Severe Rheumatoid Arthritis Patients (Ph I/I I ACTION Study)

Abstract 463 (Poster): TRU-015, a Small Modular ImmunoPharmaceutical (SMIPTM) Drug Candidate Directed Against CD20, Demonstrates Clinical Improvement in Subjects with Rheumatoid Arthritis

Abstract 725: Long-Term Efficacy and Safety of a Repeat Treatment Course of Rituximab in Rheumatoid Arthritis Patients with an Inadequate Response to One or More TNF Inhibitors

Abstract 726: TNF Inhibitors in Rheumatoid Arthritis Patients Previously Treated with Rituximab

Abstract 1234: Vaccination Against Influenza in Rheumatoid Arthritis Patients: The effect of Rituximab on the Humoral Response

Abstract 2122: HuMax-CD20, a Novel Fully Human Monoclonal IgG1 Antibody in the Treatment of Rheumatoid Arthritis